a public good project by the
Synthesis
Company
of California

© 2026

Philippe Schoeffter | doi.page

0 works0 citations0 h-index

Philippe Schoeffter

Novartis (Switzerland)(CH)Novartis Institutes for BioMedical Research

Publications by Year

Research Areas

Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Nitric Oxide and Endothelin Effects, Neuroscience and Neuropharmacology Research, Neuroendocrine Tumor Research Advances

Most-Cited Works

→ Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta(1986)296 cited
→ 5-HT Receptors: Subtypes and Second Messengers(1991)199 cited
→ Molecular pharmacology of 5-HT1D recognition sites: Radioligand binding studies in human, pig and calf brain membranes(1988)175 cited
→ Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?(1989)171 cited
→ Functional Activity of the Multiligand Analog SOM230 at Human Recombinant Somatostatin Receptor Subtypes Supports Its Usefulness in Neuroendocrine Tumors(2004)165 cited
→ Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells(2005)152 cited

→ Centrally acting hypotensive agents with affinity for 5‐HT_1A binding sites inhibit forskolin‐stimulated adenylate cyclase activity in calf hippocampus(1988)

150 cited

→ Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608)(2002)137 cited

→ 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.(1990)136 cited

→ The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra(1988)127 cited